Ryoo BY - Search Results

1

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study.

Yoo C, Kim KP, Jeong JH, Kim I, Kang MJ, Cheon J, Kang BW, Ryu H, Lee JS, Kim KW, Abou-Alfa GK, Ryoo BY. Yoo C, et al. Among authors: ryoo by. Lancet Oncol. 2021 Nov;22(11):1560-1572. doi: 10.1016/S1470-2045(21)00486-1. Epub 2021 Oct 14. Lancet Oncol. 2021. PMID: 34656226 Clinical Trial.

2

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Ryoo BY, Kang YK, Im YH, Kim YJ, Kim BS, Kim TY, Jung SH, Park JH, Baek HJ, Kim YC, Shim YM, Kim CM, Zo JI. Ryoo BY, et al. Am J Clin Oncol. 1999 Jun;22(3):253-7. doi: 10.1097/00000421-199906000-00008. Am J Clin Oncol. 1999. PMID: 10362331 Clinical Trial.

3

Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.

Park YH, Lee JC, Kim CH, Ryoo BY, Kim HT. Park YH, et al. Among authors: ryoo by. Jpn J Clin Oncol. 2004 May;34(5):245-9. doi: 10.1093/jjco/hyh043. Jpn J Clin Oncol. 2004. PMID: 15231858 Clinical Trial.

4

A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site.

Park YH, Ryoo BY, Choi SJ, Yang SH, Kim HT. Park YH, et al. Among authors: ryoo by. Jpn J Clin Oncol. 2004 Nov;34(11):681-5. doi: 10.1093/jjco/hyh124. Jpn J Clin Oncol. 2004. PMID: 15613558 Review.

5

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.

Kim TW, Kang WK, Chang HM, Park JO, Ryoo BY, Ahn JS, Zang DY, Lee KH, Kang YK, Kim SR, Kim HK; Korean Cancer Study Group. Kim TW, et al. Among authors: ryoo by. Acta Oncol. 2005;44(3):230-5. doi: 10.1080/02841860510029590. Acta Oncol. 2005. PMID: 16076694 Clinical Trial.

6

Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience.

Kim JH, Kim SY, Jung KH, Park K, Suh CW, Lim HY, Kim YH, Ryoo BY, Cho EK, Park BJ, Heo DS. Kim JH, et al. Among authors: ryoo by. Lung Cancer. 2006 Apr;52(1):75-81. doi: 10.1016/j.lungcan.2005.11.015. Epub 2006 Feb 20. Lung Cancer. 2006. PMID: 16488054 Clinical Trial.

7

High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases.

Kim HJ, Bang SM, Lee J, Kwon HC, Suh C, Kim HJ, Lee JH, Ryoo BY, Park YH, Kwon JM, Oh SY, Lee HR, Kim K, Jung CW, Park K, Kim WS. Kim HJ, et al. Among authors: ryoo by. Bone Marrow Transplant. 2006 May;37(9):819-24. doi: 10.1038/sj.bmt.1705349. Bone Marrow Transplant. 2006. PMID: 16547486

8

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

Park YH, Lee JL, Ryoo BY, Ryu MH, Yang SH, Kim BS, Shin DB, Chang HM, Kim TW, Yuh YJ, Kang YK. Park YH, et al. Among authors: ryoo by. Cancer Chemother Pharmacol. 2008 Apr;61(4):623-9. doi: 10.1007/s00280-007-0515-7. Epub 2007 May 24. Cancer Chemother Pharmacol. 2008. PMID: 17522863 Clinical Trial.

9

Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study.

Lee DH, Kim SW, Suh C, Lee JS, Lee JH, Lee SJ, Ryoo BY, Park K, Kim JS, Heo DS, Kim NK. Lee DH, et al. Among authors: ryoo by. Ann Oncol. 2008 Jan;19(1):123-7. doi: 10.1093/annonc/mdm437. Epub 2007 Sep 6. Ann Oncol. 2008. PMID: 17823384 Free article. Clinical Trial.

10

Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP.

Kang HJ, Kim WS, Suh C, Park YH, Kim BS, Yuh YJ, Ryoo BY. Kang HJ, et al. Among authors: ryoo by. Cancer Chemother Pharmacol. 2008 Jul;62(2):299-304. doi: 10.1007/s00280-007-0607-4. Epub 2007 Oct 9. Cancer Chemother Pharmacol. 2008. PMID: 17922274 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page